COLORECTAL CARCINOMA
Clinical trials for COLORECTAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new COLORECTAL CARCINOMA trials appear
Sign up with your email to follow new studies for COLORECTAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First human test of experimental cancer drug begins
Disease control TerminatedThis early-stage study tested a new cancer drug called PF-07820435, both alone and combined with an existing immunotherapy drug (sasanlimab), in people with advanced solid tumors. The main goals were to find safe doses and look for early signs that the treatment might help shrink…
Matched conditions: COLORECTAL CARCINOMA
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated Apr 01, 2026 18:41 UTC
-
First patients test new cancer drug in early safety trial
Disease control TerminatedThis was an early-stage study to test the safety and find the right dose of a new cancer drug called PF-07826390. It was given alone or combined with another immunotherapy drug to people with advanced solid tumors that had spread or stopped responding to treatment. The main goal …
Matched conditions: COLORECTAL CARCINOMA
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Two-Pronged attack tested for Tough-to-Treat colon cancer
Disease control TerminatedThis study tested a combination of two drugs, VB-111 and nivolumab, for people with advanced colorectal cancer that had spread to the liver and had stopped responding to standard chemotherapy. The main goals were to check if the treatment was safe and to see if it could cause tum…
Matched conditions: COLORECTAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC